Lynx Dx Employee Directory
Biotechnology ResearchMichigan, United States51-200 Employees
LynxDx is a biotechnology research company based in Ann Arbor, Michigan. Its core offering, MyProstateScore 2.0, is a personalized, data-driven screening solution designed to predict the presence of clinically significant prostate cancer, defined as Grade Group ≥2 or Gleason score ≥7. The tool is optimized for high accuracy in patients who have had a prior negative biopsy as well as those who are biopsy-naïve, supporting more informed diagnostic decisions. Operating in the biotechnology and diagnostic research space, LynxDx serves clinicians and patients involved in prostate cancer risk assessment. The company has expanded its footprint with facilities in Ann Arbor and an international presence in the United Kingdom, reflecting its evolving commercial and research activities. In February 2025, LynxDx began offering an at-home collection version of MyProstateScore 2.0, extending access to its screening approach.